“Pan genotypic response to combination treatment with Sofosbuvir and Daclatasvir in chronic Hepatitis C patients”, Int Jour of Biomed Res, vol. 8, no. 6, pp. 333–338, Jun. 2017, doi: 10.7439/ijbr.v8i6.4220.